A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT06618664 · RECRUITING
Trial details
- NCT number
- NCT06618664
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-28
- Primary completion
- 2026-09-01
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.